8th Risk Evaluation & Mitigation Strategies Summit

The 8th Risk Evaluation & Mitigation Strategies Summit convenes REMS stakeholders to inform the design of systems, processes, methods and components necessary for the implementation, management, assessment and modification of REMS. In addition to elucidating the impact of REMS on HCPs, pharmacies and patients, the summit also showcases best practices around emerging issues related to REMS standardization, management, evaluation and quality improvement strategies.

Learn from and interact with foremost experts, risk management leaders, crucial stakeholders, peers and preeminent thinkers that comprise our esteemed speaking faculty. Through select case studies attendees learn challenges and opportunities of risk/benefit management. Attendees develop and adapt research-based risk management strategies based on best practices, lessons learned and the needs of a broad array of stakeholders. We welcome you to witness firsthand why our event remains the conference of choice for REMS professionals.

URLs

Booking: http://atnd.it/39482-1

Price
EARLY BIRD RATE — Register by December 4, 2015: USD 1895
STANDARD RATE — Register after December 4, 2015: USD 2095

Speakers: Mary Jo Carden Vice President of Government and Pharmacy Affairs, ACADEMY OF MANAGED CARE PHARMACY - M. Soledad Cepeda Director, Epidemiology, JANSSEN - May Chan-Liston Director REMS Strategy, CELGENE CORPORATION - Ruth S. Day Director, Medical Cognition Lab, DUKE UNIVERSITY - Michael von Forstner Head of Pharmacovigilance, ACINO PHARMA - Emily Freeman Risk Management/Global Patient Safety Scientist, ASTRAZENECA - Rebekah Hanson Clinical Pharmacist, Assistant Professor of Pharmacy, UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM - Molly Billstein Leber Manager, Drug Use Policy and Formulary Management, YALE-NEW HAVEN HEALTH SYSTEM - Joanna (Asia) Lem Senior Manager, Epidemiology, PFIZER - Mandy C. Leonard System Director, Drug Use Policy and Formulary Management, Department of Pharmacy, CLEVELAND CLINIC, CLEVELAND, OHIO - Gerald K. McEvoy Assistant Vice President, AHFS Drug Information, AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS - Edward D. Millikan Director, Product Development and Maintenance, eHealth Solutions; Clinical Informaticist, AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS - Leslie S. Ritter Vice President, Public Policy, SOCIETY FOR WOMEN’S HEALTH RESEARCH (SWHR) - Paul Seligman Executive Director, Regulatory Affairs, AMGEN - Karen Smirnakis Senior Medical Director, Safety and Benefit Risk Management, BIOGEN - Rachel Sobel Senior Director, Epidemiology Group Lead, PFIZER - Carmit Strauss Global Risk Management Scientist, AMGEN - Scott Wirth Clinical Assistant Professor, Clinical Pharmacist, Oncology, UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM - Michael Wolf Professor, Medicine and Learning Sciences Associate Division Chief, Research Division of General Internal Medicine, Feinberg School of Medicine, NORTHWESTERN UNIVERSITY

Time: On Thursday January 21, 2016 at 8:00 am and ends Friday January 22, 2016 at 3:45 pm